Press Release 9/7/2021 Via Nova Therapeutics Announces $20 Million Series A Financing from Aditum Bio to Advance Four Antiviral Programs Download
Press Release 8/31/2021 Versanis Bio Announces $70 million Series A Financing to Advance Bimagrumab for the Treatment of Obesity Download
Press Release 6/30/2021 Aditum Bio Announces Formation of Ancora Bio, to Focus on Treatment-Resistant Depression Download
Press Release 11/2/2020 Aditum Bio, Co-Founded by Novartis Veterans Joe Jimenez and Dr. Mark Fishman, forms Second Company Download